Pancreatic enzyme replacement therapy in cystic fibrosis: Australian guidelines

Journal of Paediatrics and Child Health

Volumn 35, Issue 2, 1999, Pages 125-129

  Anthony, H ^a   Collins, C E ^b   Davidson, G ^c   Mews, C ^d   Robinson, P ^a   Shepherd, R ^e   Stapleton, D ^d  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b JOHN HUNTER CHILDREN S HOSPITAL   (Australia)

^c WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^d PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^e ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Clinical practice guidelines; Cystic fibrosis; Diet; Fat excretion; Malabsorption; Pancreatic enzymes

Indexed keywords

PANCREAS ENZYME;

AUSTRALIA; CLINICAL PRACTICE; CYSTIC FIBROSIS; DOSE CALCULATION; DRUG EFFICACY; ENZYME THERAPY; HUMAN; MALABSORPTION; NUTRITIONAL STATUS; PANCREAS EXOCRINE INSUFFICIENCY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TREATMENT PLANNING;

ADOLESCENT; ADULT; AUSTRALIA; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; DIETARY FATS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFANT; MALE; PANCREATIC EXTRACTS; PROGNOSIS; TREATMENT OUTCOME;

EID: 0032925860     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1754.1999.00363.x     Document Type: Review

References (42)

1. 1 Borowitz DS, Grand RJ, Durie PR. and the Consensus Committee. Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. J. Pediatr. 1995; 127: 681-4.
2. 2 Littlewood JM. Gastrointestinal complications. Br. Med. Bull. 1992; 48: 847-59.
3. 3 Gaskin K, Gurwitz D, Durie P, Corey M, Levison H, et al. Improved respiratory prognosis in patients with normal fat absorption. J. Pediatr. 1982; 100: 857-62.
4. 4 Durie PR, Pencharz PB. Nutrition: nutritional deficiencies in cystic fibrosis. Br. Med Bull. 1992; 48(4): 823-47.
5. 5 Sproul A, Huang N. Growth patterns in children with cystic fibrosis. J. Pediatr. 1964; 65: 664-76.
6. 6 Kraemer R, Rudeberg A, Hadorn B, Rossi E. Relative underweight in cystic fibrosis and its prognostic value. Acta Paediatr. Scand. 1978; 67: 33-7.
7. 7 Ramsey BW, Farrell PM, Pencharz P. Nutritional assessment and management in cystic fibrosis: a consensus report. The Consensus Committee. Am. J. Clin. Nutr. 1992; 55: 108-16.
8. 8 Corey M, McLaughlin FJ, Williams M, Levison H. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J. Clin. Epidemiol. 1988; 41: 583-91.
9. 9 Smyth RL, van Velzen D, Smyth AR, Llyod DA, Heaf DP. Strictures of ascending colon in cystic fibrosis and high strength pancreatic enzymes. Lancet 1994; 343: 85-6.
10. 10 Oades PJ, Bush A, Ong PS, Bereton RJ. High-strength pancreatic enzyme supplements and large-bowel stricture in cystic fibrosis [Letter]. Lancet 1994; 343: 109.
11. 11 Campbell CA, Forrest J, Musgrove C. High-strength pancreatic enzyme supplements and large-bowel stricture in cystic fibrosis [Letter]. Lancet 1994; 343: 109-10.
12. 12 Pawel BR, Chadarevian de JP, Franco ME. The pathology of fibrosing colonopathy of cystic fibrosis: a study of 12 cases and review of the literature. Human Pathol. 1997; 28 (4): 395-9.
13. 13 Stevens JC, Maguiness KM, Hollinsworth J, Heilman DK, Chong SFK. Pancreatic enzyme supplementation in cystic fibrosis patients before and after fibrosing colonopathy. J. Pediatr. Gastroenterol. Nutr. 1998; 26(1): 80-4.
14. 14 Committee on the Safety of Medicines. Report of the Pancreatic Enzymes Working Party. Committee on Safety of Medicines, London, 1995.
15. 15 Anthony H, Catto-Smith A, Phelan P, Paxton S. Current approaches to the nutritional management of cystic fibrosis in Australia. J. Paediatr. Child Health 1998; 34: 170-4.
16. 16 Bronstein MN, Sokol RJ, Abman SH et al. Pancreatic insufficiency, growth and nutrition in infants identified by newborn screening as having cystic fibrosis. J. Pediatr. 1992; 120: 533-40.
17. 17 Durie P, Kalnins D. Management of cystic fibrosis patients with pancreatic enzyme supplements. Pediatr. Pulmonol. 1995; Suppl. 176-7.
18. 18 Davis PB, Drumm M, Konstan MW. State of the art: Cystic Fibrosis. Am. J. Respir. Crit. Care Med. 1996; 154: 1229-56.
19. 19 Park RW, Grand RJ. Gastrointestinal manifestations of cystic fibrosis: a review. Gastroenterology 1981 ; 81: 1143-61.
20. 20 Heijerman HG. New modalities in the treatment of exocrine pancreatic insufficiency in CF. Neth. J. Med. 1992; 41(3-4): 105-9.
21. 21 Robinson P, Sly P, Smith A. Effect of Misoprostil on fat malabsorption in CF. Arch. Dis. Child 1988; 63: 1081-2.
22. 22 Robinson P, Smith A, Sly P. Duodenal pH in CF and its relationship to fat malabsorption. Dig. Dis. Sci. 1990; 35(10): 1299-304.
23. 23 Collins CE, O'Loughlin EV, Henry RL. Fat gram target to achieve high energy intake in cystic fibrosis. J. Paediatr. Child Health 1997; 31: 142-7.
24. 24 Constantini D, Padoan R, Curcio L, Giunta A. The management of enzymatic therapy in cystic fibrosis patients by a individualised approach. J. Pediatr. Gastroenterol. Nutr. 1988; 7(Suppl. 1): 36-9.
25. 25 Sturgess JM. Dietary counselling, nutritional supplementation in the treatment of cystic fibrosis, its effect on growth. Toronto, Canada: Canadian Cystic Fibrosis Foundation 1980, 161. Perspectives in Cystic Fibrosis. Proceedings of 8th International Cystic Fibrosis Congress.
26. 26 Shepherd RW, Cooksley W, Cooke W. Improved growth and clinical, nutritional and respiratory changes in response to nutritional therapy in cystic fibrosis. J. Pediatr. 1980; 97: 351-7.
27. 27 Bell L, Linton W, Corey ML, Durie P, Forstner GG. Nutrient intakes of adolescents with cystic fibrosis. J Can. Dietet. Assoc. 1981; 42(1): 62-71.
28. 28 Hubbard VS, Mangrum PJ. Energy intake and nutrition counselling in cystic fibrosis. J. Am. Diet. Assoc. 1982; 80: 127-31.
29. 29 MacDonald A, Lawson D. High, moderate or low fat diets for cystic fibrosis. Cystic Fibrosis Horizons. New York: John Wiley and Sons, 1984; 395.
30. 30 Bertrand JM, Morin CL, Lasalle R, Patrick J, Coates AL. Short-term clinical, nutritional, and functional effects of continuous elemental enteral alimentation in patients with cystic fibrosis. J. Pediatr. 1984; 104: 41-6.
31. 31 Bell L, Durie P, Forstner GG. What do children with cystic fibrosis eat? J. Pediatr. Gastroenterol. Nutr. 1984; 3 (Suppl. 1): S137-S146.
32. 32 Soutter VL, Kristidis P, Gruca MA, Gaskin KJ. Chronic undernutrition/growth retardation in cystic fibrosis. Clinics Gastroenterol. 1986; 15137-55.
33. 33 Adams L, Moss R, Hindi R, et al. Effect of nocturnal feeding via percutaneous endoscopic gastrostomy on nutrition and growth in cystic fibrosis. Cystic Fibrosis Club Abstracts 1985; 26: 83.
34. 34 Daniels L, Davidson GP, Cooper DM. Assessment of nutrient intake of patients with cystic fibrosis compared with healthy children. Hum. Nutr. Appl. Nutr. 1987; 41A: 151-9.
35. 35 Lloyd-Still JD, Smith AE, Wessel HU. Fat intake is low in cystic fibrosis despite unrestricted dietary practices. JPEN 1989; 13(3): 296-8.
36. 36 Daniels L, Davidson GP, Martin AJ. Comparison of the macronutrient intake of healthy controls and children with cystic fibrosis on low fat or nonrestricted fat diets. J. Pediatr. Gastroenterol. Nutr. 1987; 6: 381-6.
37. 37 Gaskin KJ, Waters DL, Baur LA, Soutter VL, Gruca MA. Nutritional status, growth and development in children undergoing intensive treatment for cystic fibrosis. Acta Paediatr. Scand. 1990; 366: 106-10.
38. 38 Anthony H, Bines J, Phelan P, Paxton S. Relation between nutritional status and dietary intake in CF. Arch. Dis. Child. 1998; 78(5): 443-7.
39. 39 Stapleton D, Tunnecliffe L, McGuinness D, Sheriff J, Sly P. Development of a nutrition education behaviour intervention program: go and grow with CF. Aust. J. Nutr. Diet. 1998; 55: 130-7.
40. 40 Robb T, Lewindon P, Davidson GP, Moore D, Daniels LA, Martin A. The natural history of enteric coated microsphere (pancrelipase) in a CF clinic. Pediatr. Pulmonol. 1992; (suppl.): 108-16.
41. 41 Durie, PR. Gastrointestinal and hepatic complications and their management. Int. Semin. Paediatr. Gastroenterol. Nutrition 1993; 2(2): 3-9.
42. 42 Lowdon J, Goodchild MC, Ryley H, Doull IJ. Maintenance of growth in cystic fibrosis despite reduction in pancreatic enzyme supplementation. Arch. Dis. Child. 1998; 78: 377-8.